Cargando…

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial

CONTEXT AND OBJECTIVE: Prader-Willi syndrome (PWS) is characterized by early-onset hyperphagia and increased circulating levels of the orexigenic Acylated Ghrelin (AG) hormone with a relative deficit of Unacylated Ghrelin (UAG). AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allas, Soraya, Caixàs, Assumpta, Poitou, Christine, Coupaye, Muriel, Thuilleaux, Denise, Lorenzini, Françoise, Diene, Gwenaëlle, Crinò, Antonino, Illouz, Frédéric, Grugni, Graziano, Potvin, Diane, Bocchini, Sarah, Delale, Thomas, Abribat, Thierry, Tauber, Maithé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761957/ https://www.ncbi.nlm.nih.gov/pubmed/29320575 http://dx.doi.org/10.1371/journal.pone.0190849

Ejemplares similares

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531
por: Au, CheukMan C, et al.
Publicado: (2020)

Hyponatremia in Children and Adults with Prader–Willi Syndrome: A Survey Involving Seven Countries
por: Coupaye, Muriel, et al.
Publicado: (2021)

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
por: Allas, Soraya, et al.
Publicado: (2019)

Causes of death in Prader-Willi syndrome: lessons from 11 years’ experience of a national reference center
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2019)

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome
por: Kuppens, R. J., et al.
Publicado: (2015)

High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome
por: Beauloye, Veronique, et al.
Publicado: (2016)

Diabetes Mellitus in Prader-Willi Syndrome: Natural History during the Transition from Childhood to Adulthood in a Cohort of 39 Patients
por: Clerc, Alice, et al.
Publicado: (2021)

Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study
por: Consoli, Angèle, et al.
Publicado: (2019)

OR05-5 AZP-3404, a 9-Amino Acid Peptide Analog of Insulin-Like Growth Factor-Binding Protein 2, Reverses Insulin Resistance in Leptin-Deficient ob/ob Mice
por: Milano, Stephane, et al.
Publicado: (2019)

OR27-5 Malignancies in Prader-Willi Syndrome: Practical Recommendations Based on a Large International Cohort
por: Caixàs, Assumpta, et al.
Publicado: (2022)

Physical Activity in Patients with Prader-Willi Syndrome—A Systematic Review of Observational and Interventional Studies
por: Bellicha, Alice, et al.
Publicado: (2021)

Paradoxical low severity of COVID-19 in Prader-Willi syndrome: data from a French survey on 647 patients
por: Coupaye, Muriel, et al.
Publicado: (2021)

Effects of the COVID-19 pandemic and lockdown on the mental and physical health of adults with Prader-Willi syndrome
por: Mosbah, Helena, et al.
Publicado: (2021)

Central Adrenal Insufficiency Is Rare in Adults With Prader–Willi Syndrome
por: Rosenberg, Anna G W, et al.
Publicado: (2020)

Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients
por: Tauber, Maïthe, et al.
Publicado: (2011)

French database of children and adolescents with Prader-Willi syndrome
por: Molinas, Catherine, et al.
Publicado: (2008)

SUN-308 Central Adrenal Insufficiency Is Rare in Adults with Prader-Willi Syndrome
por: Rosenberg, Anna G W, et al.
Publicado: (2020)

Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome
por: Bar, Céline, et al.
Publicado: (2017)

Behavioral profile of adults with Prader-Willi syndrome: correlations with individual and environmental variables
por: Jauregi, Joseba, et al.
Publicado: (2013)

Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review
por: Pellikaan, Karlijn, et al.
Publicado: (2023)

Obesity management in Prader–Willi syndrome: current perspectives
por: Crinò, Antonino, et al.
Publicado: (2018)

Equivocal expression of emotions in children with Prader-Willi syndrome: what are the consequences for emotional abilities and social adjustment?
por: Famelart, Nawelle, et al.
Publicado: (2020)

What underlies emotion regulation abilities? An innovative programme based on an integrative developmental approach to improve emotional competencies: Promising results in children with Prader–Willi syndrome
por: Famelart, Nawelle, et al.
Publicado: (2022)

Congenital hypothyroidism due to ectopic sublingual thyroid gland in Prader-Willi Syndrome: a case report
por: Bocchini, Sarah, et al.
Publicado: (2017)

Face processing and exploration of social signals in Prader-Willi syndrome: a genetic signature
por: Debladis, Jimmy, et al.
Publicado: (2019)

Bone Health in Adults With Prader–Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study
por: van Abswoude, Denise H, et al.
Publicado: (2022)

Liraglutide for Weight Management in Children and Adolescents With Prader–Willi Syndrome and Obesity
por: Diene, Gwenaëlle, et al.
Publicado: (2022)

AZP-3404, a Peptide Analog of IGFBP-2, Induces Weight Loss and Improves Glucose Metabolism in Leptin-Resistant db/db Mice
por: Culler, Michael D, et al.
Publicado: (2021)

A study of voice and non-voice processing in Prader-Willi syndrome
por: Strenilkov, Kuzma, et al.
Publicado: (2020)

Is ghrelin a biomarker of early-onset scoliosis in children with Prader–Willi syndrome?
por: Pacoricona Alfaro, Dibia Liz, et al.
Publicado: (2021)

Impact du confinement lié au COVID-19 chez les adultes présentant un syndrome de Prader-Willi
por: Mosbah, H., et al.
Publicado: (2020)

Impact of Deprivation on Obesity in Children with PWS
por: Grolleau, Sabrina, et al.
Publicado: (2022)

Hypogonadism in Adult Males with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

The transition from pediatric to adult care in individuals with Prader-Willi syndrome
por: Poitou, Christine, et al.
Publicado: (2022)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

Multidrug Resistance in Rat Colon Carcinoma Cell Lines CC531, CC531(mdr+) and CC531(rev)
por: Gheuens, Eric, et al.
Publicado: (1993)

Antifibrotic Activity of Acylated and Unacylated Ghrelin
por: Angelino, Elia, et al.
Publicado: (2015)

Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review
por: van Abswoude, Denise H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_879gqrgkcgn2uhe8tbpod2hgf0